Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
3.675
+0.065 (1.80%)
At close: Nov 4, 2024, 4:00 PM
3.580
-0.095 (-2.59%)
After-hours: Nov 4, 2024, 4:23 PM EST
Kiora Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | 3.2 | -12.51 | -13.58 | -13.77 | -6.86 | -7.1 | |
| Depreciation & Amortization | -0 | 0.06 | 0.13 | 0.23 | 0.2 | 0.21 | |
| Loss (Gain) From Sale of Assets | -0.03 | -0.03 | -0 | - | - | - | |
| Asset Writedown & Restructuring Costs | 1.9 | 1.9 | - | 4.04 | - | - | |
| Stock-Based Compensation | 0.77 | 0.75 | 0.46 | 0.84 | 0.72 | 0.85 | |
| Other Operating Activities | 1.84 | 2.08 | 1.89 | -0.98 | -1.06 | 0.6 | |
| Change in Accounts Receivable | -1.34 | - | - | - | - | - | |
| Change in Accounts Payable | 0.12 | -0.81 | 0.78 | -0.31 | 0.14 | 0.15 | |
| Change in Unearned Revenue | - | - | - | - | - | -2.69 | |
| Change in Income Taxes | -1.42 | -0.55 | -0.87 | -0.44 | - | - | |
| Change in Other Net Operating Assets | -0.19 | -0.47 | 0.76 | -0.28 | -0.44 | -0.19 | |
| Operating Cash Flow | 4.79 | -9.56 | -10.43 | -10.68 | -7.32 | -8.15 | |
| Capital Expenditures | -0.05 | - | - | -0.06 | -0.02 | - | |
| Sale of Property, Plant & Equipment | - | - | 0.01 | - | - | - | |
| Cash Acquisitions | - | - | - | -0.09 | -0.11 | - | |
| Divestitures | - | - | - | - | -0.11 | - | |
| Investing Cash Flow | -21.22 | - | 0.01 | -0.16 | -0.24 | - | |
| Long-Term Debt Issued | - | - | - | - | 0.28 | - | |
| Total Debt Issued | - | - | - | - | 0.28 | - | |
| Long-Term Debt Repaid | - | - | - | -0.21 | - | -0 | |
| Net Debt Issued (Repaid) | - | - | - | -0.21 | 0.28 | -0 | |
| Issuance of Common Stock | 15.88 | 6.46 | 5.9 | 17.8 | 5.22 | 4.03 | |
| Repurchase of Common Stock | - | - | -0.02 | - | - | -0 | |
| Other Financing Activities | -0.87 | -0.5 | 2.74 | - | -0.5 | -0.1 | |
| Financing Cash Flow | 15.01 | 5.97 | 8.62 | 17.58 | 5 | 3.92 | |
| Foreign Exchange Rate Adjustments | 0.05 | 0.04 | -0.09 | -0.08 | -0.03 | 0.01 | |
| Net Cash Flow | -1.38 | -3.55 | -1.89 | 6.67 | -2.59 | -4.23 | |
| Free Cash Flow | 4.74 | -9.56 | -10.43 | -10.74 | -7.34 | -8.15 | |
| Free Cash Flow Margin | 29.57% | - | - | - | -60844.56% | -303.57% | |
| Free Cash Flow Per Share | 1.97 | -17.76 | -128.16 | -400.88 | -575.29 | - | |
| Levered Free Cash Flow | 1.47 | -6.77 | -5.02 | -6.44 | -3.39 | -5.67 | |
| Unlevered Free Cash Flow | 1.48 | -6.76 | -5.01 | -6.43 | -3.39 | -5.67 | |
| Change in Net Working Capital | 3.17 | 2.15 | -1.1 | 0.83 | -0.4 | 2.6 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.